The UCSF Helen Diller Family Comprehensive Cancer Center is the only center in the San Francisco area to receive the prestigious designation of "comprehensive" from the National Cancer Institute. We treat all forms of cancer. With new facilities, expanded programs and innovative research, we help cancer patients live longer and fuller lives. The center ranks first in California and sixth nationwide in National Cancer Institute research grants, and is home to pioneers in research into genetic, cellular and immune system causes and responses to cancer.
Featured Videos View All »
Video
Advances in Breast Cancer Care: Individualized Screening, Treatments and Follow-Up
Karen Goodwin, DO, covers everything from how to answer patients’ questions on mammogram frequency to how to counsel them on breast cancer prevention.
Video
Navigating the Maze of Breast Cancer Guidelines: Efficient Paths to Personalized Screening
To help PCPs address patients’ breast cancer screening concerns, surgeon Shoko Emily Abe, MD, FACS, breaks down the multitude of screening directives and modalities, with a focus on the needs of those at average risk and those with dense breast tissue.
Video
Lung Cancer Screening: Who, How and When to Refer
†horacic radiologist Brett M. Elicker, MD, and thoracic surgeon Johannes Kratz, MD, present about current lung cancer screening guidelines: who, how, and when to refer.
Video
UCSF Osher Center Overview: Integrative Medicine’s Value for Providers and Patients
Sanford C. Newmark, MD, medical director of the UCSF Osher Center for Integrative Medicine, explains what integrative medicine is (hint: it’s neither “alternative medicine” nor homeopathy) and how referred patients can benefit from its proven techniques.
Articles & Documents View All »
News
First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.
Document
Cardio-Oncology & Immunology: Specialized Cardiovascular Care for Cancer Patients
Led by a multidisciplinary team of specialists and researchers, our program optimizes the cardiovascular health of cancer patients and cancer survivors.
News
Patients with a detectable prostate-specific antigen (PSA) after radical prostatectomy (RP) may have excellent long-term outcomes, according to two retrospective studies conducted by UCSF researchers.
News
UCSF Surgical Oncologists Present Clinical Findings at International Conference
The latest advances in surgical cancer care and research were showcased at the Society of Surgical Oncology’s (SSO) Annual Meeting, the International Conference on Surgical Cancer Care. The meeting was held in Boston, from March 22 – 25, 2023.
The UCSF Helen Diller Family Comprehensive Cancer Center is the only center in the San Francisco area to receive the prestigious designation of "comprehensive" from the National Cancer Institute. We treat all forms of cancer. With new facilities, expanded programs and innovative research, we help cancer patients live longer and fuller lives. The center ranks first in California and sixth nationwide in National Cancer Institute research grants, and is home to pioneers in research into genetic, cellular and immune system causes and responses to cancer.
